Know Labs Expands Leadership Team for Future Growth
Know Labs, Inc. (NYSE American: KNW), a pioneer in the development of non-invasive diagnostic technology, has recently made significant changes to its executive leadership team. The announcement includes the addition of two prominent figures, John Cronin and Dominic Klyve, Ph.D., who will play vital roles in enhancing the Company’s innovative diagnostic technology platform and fostering strategic partnerships.
Insights from the CEO
Ron Erickson, CEO of Know Labs, expressed optimism about the new appointments, highlighting the robust technology leadership and research experience they bring. "John and Dominic will contribute intellectual guidance to propel our technology development forward, as well as offer valuable business insights to support our market entry through alliances with industry leaders across the med tech, pharmaceutical, and consumer sectors,” he stated.
John Cronin Takes the Helm as Interim CTO
John Cronin steps in as the Interim Chief Technology Officer, bringing a wealth of experience from his previous role on the Company’s Board of Directors. As a strategic advisor, he has been instrumental in expanding Know Labs' patent portfolio, solidifying its position as a leader in non-invasive glucose monitoring technologies. Cronin will oversee the Company’s product development, spearheading technology strategies and research protocols.
Innovative Projects and Skunkworks Initiatives
In addition to his executive responsibilities, Cronin is in charge of the Company’s “skunkworks” projects, which are focused on exploring groundbreaking applications for its sensor platform. An exciting instance of this innovation is the recent work on incorporating sensor technology into automobile steering wheels, aimed at promoting safer driving.
Welcoming Dr. Dominic Klyve as Chief Science Officer
Dominic Klyve, Ph.D., a long-time collaborator with Know Labs, has been appointed Chief Science Officer. A former lead data scientist, Klyve will now lead the research and development efforts dedicated to creating the first-ever non-invasive glucose monitoring device. His extensive experience includes contributions to significant published studies and management of high-value research grants from organizations like the National Science Foundation.
Academic Contributions and Expertise
Dr. Klyve is a noted author with over 80 peer-reviewed publications in various scientific and mathematical fields. His academic role extends to a professorship at Central Washington University, where he currently is on sabbatical. Klyve’s deep understanding of RF sensing technologies and machine learning algorithms will be pivotal in advancing Know Labs' initiatives.
About Know Labs, Inc.
Know Labs, Inc. operates publicly under the ticker KNW on the NYSE American Exchange. The Company focuses on leveraging spectroscopy for non-invasive diagnostic solutions. Their technology captures distinct molecular signatures, enabling integration into various platforms—wearable, mobile, or bench-top.
The primary goal of this pioneering technology is to facilitate real-time, cost-effective blood glucose level monitoring, making vital health information accessible to users. This forthcoming glucose monitor will be subjected to regulatory approval by the U.S. Food and Drug Administration before reaching the market.
Frequently Asked Questions
What recent changes have occurred in Know Labs' leadership?
Know Labs has appointed John Cronin as Interim Chief Technology Officer and Dominic Klyve, Ph.D., as Chief Science Officer to enhance their technology and research capabilities.
What are the primary roles of the new executives?
John Cronin is focused on product development and technology strategy, while Dr. Klyve leads research efforts aimed at developing non-invasive glucose monitoring solutions.
How does Know Labs' technology work?
The technology utilizes spectroscopy to analyze substances and capture unique molecular signatures, designed for use in various diagnostic formats.
What is the expected application of Know Labs' technology?
The first application aims to be a non-invasive glucose monitor, providing users with immediate feedback on their blood glucose levels in a convenient manner.
Where can I find more information about Know Labs?
For additional insights about Know Labs and their products, individuals can visit their official website, www.knowlabs.co.
